BPTH - Bio-Path Holdings Inc Stock Price, Fair Value and News

$1.26-0.23 (-15.44%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

BPTH Price Action

Last 7 days

90.9%

Last 30 days

59.5%

Last 90 days

41.6%

Trailing 12 Months

-85.7%

BPTH RSI Chart

BPTH Valuation

Market Cap

5.4M

Price/Earnings (Trailing)

-0.52

EV/EBITDA

-0.62

Price/Free Cashflow

-0.57

MarketCap/EBT

-0.71

BPTH Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

BPTH Fundamentals

BPTH Earnings

Earnings (TTM)

-10.5M

Earnings Growth (Yr)

33.89%

Earnings Growth (Qtr)

-13.16%

BPTH Profitability

Return on Equity

1.5K%

Return on Assets

-354.57%

Free Cashflow Yield

-175.21%

BPTH Investor Care

Shares Dilution (1Y)

597.32%

Diluted EPS (TTM)

-10.57

Revenue & Growth

About Bio-Path Holdings Inc

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 (BP1002) for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 (BP1003) for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and BP1001-A for the treatment of solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.

CEO	Mr. Peter H. Nielsen MBA
WEBSITE	biopathholdings.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	10

Bio-Path Holdings Inc Frequently Asked Questions

What is the ticker symbol for Bio-Path Holdings Inc? What does BPTH stand for in stocks?

BPTH is the stock ticker symbol of Bio-Path Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Bio-Path Holdings Inc (BPTH)?

As of Fri Dec 20 2024, market cap of Bio-Path Holdings Inc is 5.43 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BPTH stock?

You can check BPTH's fair value in chart for subscribers.

Is Bio-Path Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether BPTH is over valued or under valued. Whether Bio-Path Holdings Inc is cheap or expensive depends on the assumptions which impact Bio-Path Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BPTH.

What is 5 year return on Bio-Path Holdings Inc's stock?

In the past 10 years, Bio-Path Holdings Inc has provided -0.597 (multiply by 100 for percentage) rate of return.